Poke Not Prod: First Canadian Experience Using Donor-Derived Cell Free DNA to Replace Endomyocardial Biopsy During COVID-19

PURPOSE: After a heart transplant (HT), non-invasive methods for rejection surveillance minimize the need for endomyocardial biopsies (EMBx). We describe the first experience with combined use of genetic expression profiling (GEP) and donor-derived cell-free DNA (dd-cfDNA) testing in Canada as part...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodenas-Alesina, E., Amadio, J.M., Superina, S., Kozuszko, S., Tsang, K., Simard, A., Aleksova, N., Kobulnik, J., Fan, C., Wijeysundera, H.C., Ross, H.J., McDonald, M.A., Duero-Posada, J.G., Moayedi, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(280)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988591/
http://dx.doi.org/10.1016/j.healun.2022.01.301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988591/
http://dx.doi.org/10.1016/j.healun.2022.01.301

Ejemplares similares